Erratum to “Letter to the Editor: Comment on ‘Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions’’’ [Lung Cancer 159 (2021) 127]

Lung Cancer ◽

10.1016/j.lungcan.2021.09.006 ◽

2021 ◽

Author(s):

Alexander P.W.M. Maat ◽

Robin Cornelissen ◽

Ad J.J.C. Bogers ◽

Edris A.F. Mahtab

Keyword(s):

Lung Cancer ◽

Medical Therapy ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Academic Institutions ◽

Trimodality Therapy ◽

Editor Comment ◽

Letter To The Editor

Download Full-text

Letter to the Editor: Comment on ‘Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions’

Lung Cancer ◽

10.1016/j.lungcan.2021.06.016 ◽

2021 ◽

Keyword(s):

Medical Therapy ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Academic Institutions ◽

Trimodality Therapy ◽

Editor Comment ◽

Letter To The Editor

Download Full-text

MALIGNANT PLEURAL MESOTHELIOMA: COMPARISON OF SURGERY-BASED TRIMODALITY THERAPY TO MEDICAL THERAPY AT TWO TERTIARY ACADEMIC INSTITUTIONS

Lung Cancer ◽

10.1016/j.lungcan.2021.04.025 ◽

2021 ◽

Author(s):

Frédéric Larose ◽

Nicholas Quigley ◽

Yves Lacasse ◽

Simon Martel ◽

Loïc Lang-Lazdunski

Keyword(s):

Medical Therapy ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Academic Institutions ◽

Trimodality Therapy

Download Full-text

Faculty Opinions recommendation of Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732234862.793551909 ◽

2018 ◽

Author(s):

Paul Van Schil

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Trimodality Therapy

Download Full-text

Is ?7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Current Drug Targets ◽

10.2174/138945012800398900 ◽

2012 ◽

Vol 13 (5) ◽

pp. 688-694 ◽

Cited By ~ 18

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

Comments on ‘High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients’

European Journal of Cancer ◽

10.1016/j.ejca.2021.03.055 ◽

2021 ◽

Author(s):

Akio Hara ◽

Masanori Matsuda ◽

Arata Ishii ◽

Takashi Yoshioka

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Malignant Pleural Mesothelioma ◽

High Intensity ◽

Small Cell ◽

Clinical Activity ◽

Pleural Mesothelioma ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Immunotherapy for Lung Cancer and Malignant Pleural Mesothelioma

Cancer Immunotherapy Principles and Practice ◽

10.1891/9780826137432.0057 ◽

2021 ◽

Author(s):

Paola Ghanem ◽

Julie R Brahmer

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.04.029 ◽

2019 ◽

Vol 14 (8) ◽

pp. 1343-1353 ◽

Cited By ~ 12

Author(s):

Joseph S. Friedberg ◽

Melissa J. Culligan ◽

Anne S. Tsao ◽

Valerie Rusch ◽

Boris Sepesi ◽

...

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

National Cancer Institute ◽

Applied Research ◽

International Association ◽

Pleural Mesothelioma

Download Full-text

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.03.030 ◽

2019 ◽

Vol 14 (7) ◽

pp. 1172-1183 ◽

Cited By ~ 12

Author(s):

Daniel R. Gomez ◽

Andreas Rimner ◽

Charles B. Simone ◽

B.C. John Cho ◽

Marc de Perrot ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Expert Opinion ◽

Malignant Pleural Mesothelioma ◽

National Cancer Institute ◽

Applied Research ◽

International Association ◽

Steering Committee ◽

Pleural Mesothelioma ◽

Thoracic Malignancy

Download Full-text

A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7021 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7021-7021 ◽

Cited By ~ 12

Author(s):

J. P. Van Meerbeeck ◽

C. Manegold ◽

R. Gaafar ◽

R. J. van Klaveren ◽

E. A. Van Marck ◽

...

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Cancer Group ◽

Phase Iii Study

Download Full-text

A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7021 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7021-7021 ◽

Cited By ~ 1

Author(s):

J. P. Van Meerbeeck ◽

C. Manegold ◽

R. Gaafar ◽

R. J. van Klaveren ◽

E. A. Van Marck ◽

...

Keyword(s):

Lung Cancer ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Cancer Group ◽

Phase Iii Study

Download Full-text